Cryopreservation of primary human hepatocytes: The benefit of trehalose as an additional cryoprotective agent
Open Access
- 27 December 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 13 (1) , 38-45
Abstract
Problems with the limited availability of human hepatocytes for cell transplantation may be overcome by efficient cryopreservation techniques and formation of appropriate cell banking. In this study we investigated the effect of the disaccharide trehalose on the cryopreservation of human hepatocytes. For analysis, liver cells were frozen in culture medium containing 10% dimethyl sulfoxide (DMSO) that was supplemented with varying concentrations of trehalose. During the postthawing culture period, viability, plating efficiency, total protein, cell proliferation, enzyme leakage, albumin and urea formation, as well as phase I and II metabolism were analyzed. In the pilot study, among the concentrations investigated, 0.2 M trehalose showed the best overall outcome. Compared to the use of DMSO alone, we found significant improvement in postthaw cell viability (62.9 ± 13 vs. 46.9 ± 11%, P < 0.01) and plating efficiency (41.5 ± 18 vs. 17.6 ± 13%, P < 0.01) in the trehalose group. The use of trehalose as an additive for cryopreserving human hepatocytes resulted in a significantly increased total protein level in the attached cells, higher secretion of albumin and a lower aspartate aminotransferase (AST) level after thawing. In conclusion, the use of trehalose as cryoprotective agent significantly improves the outcome of human hepatocyte cryopreservation. Liver Transpl, 2007. © 2006 AASLD.Keywords
This publication has 31 references indexed in Scilit:
- Hepatocyte Transplantation for Metabolic Liver Disease: UK ExperienceJournal of the Royal Society of Medicine, 2005
- Cryopreservation of hepatocytes: a review of current methods for bankingCell and Tissue Banking, 2003
- Cryopreservation of adult human hepatocytes obtained from resected liver biopsiesCryobiology, 2002
- Cryopreservation of Human Hematopoietic Cells with Membrane Stabilizers and Bioantioxidants as Additives in the Conventional Freezing MediumJournal of Hematotherapy & Stem Cell Research, 2001
- CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*Drug Metabolism Reviews, 2000
- Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panelChemico-Biological Interactions, 1999
- Dimethyl sulphoxide: A review of its applications in cell biologyBioscience Reports, 1994
- A New Technique for Isolating and Culturing Human Hepatocytes from Whole or Split Livers not Used for TransplantationCell Transplantation, 1994
- Antioxidant protection against organic and inorganic oxygen radicals by normal human plasma: the important primary role for iron-binding and iron-oxidising proteinsBiochimica et Biophysica Acta (BBA) - General Subjects, 1993
- Prevention of Freezing Damage to Living Cells by Dimethyl SulphoxideNature, 1959